RIA Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-259
Closed -$310K – 154
2026
Q2
$310K Buy
+259
New +$265K 0.07% 118
2024
Q4
– Sell
-319
Closed -$282K – 144
2024
Q3
$282K Buy
+319
New +$287K 0.1% 101
2024
Q1
$315K Buy
+405
New +$288K 0.13% 95
2023
Q4
– Sell
-842
Closed -$452K – 154
2023
Q3
$452K Buy
+842
New +$434K 0.2% 66

Other funds holding LLY

RIA Advisory Group's LLY Position: Q3 2026 in Review

RIA Advisory Group sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 259 shares — an estimated $310K sold.

RIA Advisory Group first reported a position in LLY in Q3 2023 and held it in 4 quarters. The position peaked at $452K in Q3 2023. 1,195 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RIA Advisory Group reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
  • RIA Advisory Group sold 259 Eli Lilly shares in Q3 2026, an estimated $310K.
  • RIA Advisory Group first reported a position in Eli Lilly in Q3 2023 and held it in 4 quarters.
  • RIA Advisory Group's Eli Lilly position peaked at $452K in Q3 2023.
  • 1,195 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RIA Advisory Group's 13F filing for Q3 2026, filed 15 Oct 2026.